NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 308 filers reported holding NATERA INC in Q4 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,476,283 | +14.5% | 259,351 | +25.9% | 0.00% | 0.0% |
Q2 2023 | $10,019,922 | -43.2% | 205,917 | -35.2% | 0.00% | -50.0% |
Q1 2023 | $17,636,371 | +110.7% | 317,658 | +52.5% | 0.00% | +100.0% |
Q4 2022 | $8,369,339 | +6.2% | 208,348 | +15.9% | 0.00% | 0.0% |
Q3 2022 | $7,879,000 | -8.3% | 179,821 | -25.8% | 0.00% | 0.0% |
Q2 2022 | $8,590,000 | -43.7% | 242,381 | -35.4% | 0.00% | 0.0% |
Q1 2022 | $15,264,000 | -35.8% | 375,216 | +47.4% | 0.00% | -50.0% |
Q4 2021 | $23,765,000 | -31.9% | 254,471 | -18.7% | 0.00% | -50.0% |
Q3 2021 | $34,895,000 | -8.7% | 313,122 | -7.0% | 0.00% | 0.0% |
Q2 2021 | $38,231,000 | +5.4% | 336,746 | -5.8% | 0.00% | 0.0% |
Q1 2021 | $36,283,000 | +18.3% | 357,316 | +16.0% | 0.00% | 0.0% |
Q4 2020 | $30,659,000 | +76.2% | 308,068 | +27.9% | 0.00% | +100.0% |
Q3 2020 | $17,397,000 | +11.4% | 240,824 | -23.1% | 0.00% | 0.0% |
Q2 2020 | $15,621,000 | +92.1% | 313,296 | +15.1% | 0.00% | +100.0% |
Q1 2020 | $8,130,000 | +1.6% | 272,261 | +14.7% | 0.00% | 0.0% |
Q4 2019 | $7,999,000 | +3.6% | 237,423 | +0.9% | 0.00% | 0.0% |
Q3 2019 | $7,721,000 | +5.3% | 235,407 | -11.4% | 0.00% | 0.0% |
Q2 2019 | $7,329,000 | +43.1% | 265,773 | +7.0% | 0.00% | 0.0% |
Q1 2019 | $5,123,000 | +125.5% | 248,440 | +52.7% | 0.00% | – |
Q4 2018 | $2,272,000 | -49.8% | 162,741 | -13.9% | 0.00% | -100.0% |
Q3 2018 | $4,528,000 | +106.4% | 189,108 | +62.2% | 0.00% | – |
Q2 2018 | $2,194,000 | +151.6% | 116,568 | +23.9% | 0.00% | – |
Q1 2018 | $872,000 | +17.0% | 94,070 | +13.5% | 0.00% | – |
Q4 2017 | $745,000 | -52.5% | 82,869 | -31.9% | 0.00% | – |
Q3 2017 | $1,570,000 | +86.0% | 121,770 | +56.9% | 0.00% | – |
Q2 2017 | $844,000 | +40.0% | 77,630 | +14.2% | 0.00% | – |
Q1 2017 | $603,000 | +45.0% | 67,977 | +91.2% | 0.00% | – |
Q4 2016 | $416,000 | +14.6% | 35,549 | +8.7% | 0.00% | – |
Q3 2016 | $363,000 | +1810.5% | 32,700 | +1933.6% | 0.00% | – |
Q2 2016 | $19,000 | +533.3% | 1,608 | +564.5% | 0.00% | – |
Q4 2015 | $3,000 | -83.3% | 242 | -85.2% | 0.00% | – |
Q3 2015 | $18,000 | – | 1,637 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |